Rocket pharmaceuticals, inc. (RCKT)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14
Assets
Current assets:
Cash and cash equivalents

190,520

185,383

89,195

64,833

124,464

111,355

38,076

52,548

171,136

18,142

49,146

27,610

25,273

29,798

83,004

38,519

58,706

80,042

89,248

49,012

53,139

3,618

Investments

85,375

118,732

151,366

192,950

72,126

94,375

89,402

79,555

11,561

0

53,979

81,144

89,432

96,675

54,579

59,703

43,559

31,238

29,117

-

-

-

Prepaid expenses and other assets

3,910

3,639

5,030

5,846

3,029

3,358

1,343

2,505

2,131

813

747

1,067

1,928

1,876

1,341

480

982

1,086

859

465

301

52

Total current assets

279,805

307,754

245,591

263,629

199,619

209,088

128,821

134,608

184,828

18,955

103,872

109,821

116,633

128,349

138,924

98,702

103,247

112,366

119,224

49,477

53,440

3,670

Property and equipment, net

11,140

29,521

19,270

9,844

7,077

2,027

1,245

976

1,146

985

615

1,076

1,122

1,130

1,045

976

790

812

756

29

-

-

Goodwill

30,815

30,815

30,815

30,815

30,815

30,815

30,815

30,815

30,815

0

-

-

-

-

-

-

-

-

-

-

-

-

Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business for the internal use software.

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

1,525

1,525

1,525

1,525

1,525

1,436

1,645

1,644

208

207

-

-

-

-

-

-

-

-

-

-

-

-

Deposits

455

455

455

455

455

545

455

168

168

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating right-of-use assets

1,470

2,051

2,254

2,452

2,647

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance right-of-use assets

47,541

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investments

-

-

0

0

0

7,402

32,000

39,363

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

-

-

-

-

-

-

168

168

168

168

170

173

170

143

144

2,182

2,086

1,850

Total assets

372,751

372,121

299,910

308,720

242,138

251,313

194,981

207,574

217,165

20,147

104,655

111,065

117,923

129,647

140,139

99,851

104,207

113,321

120,124

51,688

55,526

5,520

Liabilities and stockholders' equity
Current liabilities:
Accounts payable and accrued expenses

18,819

17,352

21,246

14,168

19,680

15,372

9,765

8,285

4,762

4,521

-

-

-

-

-

-

-

-

-

-

-

-

Operating current lease liabilities

817

957

935

913

892

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease liabilities, current

1,478

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued research and development costs

-

-

-

-

-

-

529

1,861

2,575

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

383

368

1,902

1,592

1,777

921

1,376

1,633

1,709

813

1,301

1,146

Accrued expenses and other current liabilities

-

-

-

-

-

-

-

-

-

-

2,900

2,423

2,886

4,246

3,716

3,150

3,238

2,508

1,534

1,273

1,052

992

Accrued interest

-

-

-

-

-

-

-

-

-

-

484

1,225

480

1,204

451

-

-

-

-

366

104

-

Notes payable, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,063

Convertible Bridge Notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,541

Convertible Bridge Notes redemption rights derivative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

480

Total current liabilities

21,114

18,309

22,181

15,081

20,572

15,372

10,294

10,146

7,337

4,521

3,767

4,016

5,268

7,042

5,944

4,071

4,614

4,141

3,243

2,452

2,457

7,222

Convertible notes, net of unamortized discount

45,794

45,049

44,097

43,180

42,297

41,447

40,629

39,842

39,084

0

-

-

-

-

-

-

-

-

-

8,926

8,667

-

Operating noncurrent lease liabilities

917

1,443

1,691

1,933

2,169

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance noncurrent lease liability

18,852

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and lease obligations

-

-

-

-

-

-

438

510

598

107

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,550

Warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

482

2020 Convertible Notes derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,567

10,426

-

Other liabilities

23

23

23

22

23

457

-

-

-

-

423

277

292

477

321

336

351

367

406

24

24

24

Total liabilities

86,700

64,824

67,992

60,216

65,061

57,276

51,361

50,498

47,019

4,628

53,580

53,535

54,659

56,479

55,085

4,407

4,965

4,508

3,649

19,969

21,574

10,278

Redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

46,801

Commitments and contingencies (Note 11)

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Common stock, $0.01 par value, 120,000,000 shares authorized; 55,157,035 and 54,773,061 shares issued and 55,126,474 and 54,769,030 shares outstanding at March 31, 2020 and December 31, 2019, respectively

551

548

503

503

451

452

398

395

394

68

272

270

270

67

269

269

264

264

264

163

163

10

Treasury stock

429

53

344

344

0

668

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

493,811

489,925

394,930

392,205

302,039

300,253

221,983

219,225

216,440

5,340

314,332

313,441

312,613

312,032

310,686

309,933

305,069

304,583

304,062

163,446

163,292

76,472

Accumulated other comprehensive loss (income)

-75

20

117

144

-89

-127

-207

-79

10

0

-25

-72

-72

-54

2

17

-

-11

-

-

-

-

Accumulated deficit

-207,807

-183,143

-163,288

-144,004

-125,324

-105,873

-78,554

-62,465

-46,698

-31,355

-263,504

-256,109

-249,547

-238,877

-225,903

-214,775

-206,091

-196,023

-187,851

-131,890

-129,503

-128,041

Total stockholders' equity

286,051

307,297

231,918

248,504

177,077

194,037

143,620

157,076

170,146

15,519

51,075

57,530

63,264

73,168

85,054

95,444

99,242

108,813

116,475

31,719

33,952

-51,559

Total liabilities and stockholders' equity

372,751

372,121

299,910

308,720

242,138

251,313

194,981

207,574

217,165

20,147

104,655

111,065

117,923

129,647

140,139

99,851

104,207

113,321

120,124

51,688

55,526

5,520

2021 Convertible Notes [Member]
2021 Convertible Notes, net of issuance costs

-

-

-

-

-

-

-

-

-

-

49,390

49,242

49,099

-

-

-

-

-

-

-

-

-

Series A preferred stock that may be exchanged into common shares or other types of securities at the owner's option.
Preferred stock

0

0

0

0

0

0

0

0

0

16,060

-

-

-

-

-

-

-

-

-

-

-

-

Series B preferred stock that may be exchanged into common shares or other types of securities at the owner's option.
Preferred stock

0

0

0

0

0

0

0

0

0

25,406

-

-

-

-

-

-

-

-

-

-

-

-